Search Results - "Coulibaly, Hamadou"

Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation (INVENT VPT) Trial: study protocol for a randomized controlled crossover trial by Ervin, Ann-Margret, Schubert, Michael C, Migliaccio, Americo A, Perin, Jamie, Coulibaly, Hamadou, Millar, Jennifer L, Roberts, Dale, Shelhamer, Mark, Gold, Daniel, Beauregard, Stephanie, Pinto, Robin, Brungart, Douglas, Ward, Bryan K

“…A clinical pattern of damage to the auditory, visual, and vestibular sensorimotor systems, known as multi-sensory impairment, affects roughly 2% of the US…”
Get full text

Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys by Georges, Guiella, Shani, Turke, Hamadou, Coulibaly, Radloff, Scott, Yoonjoung, Choi

“…The subcutaneous (SC) injectable, widely known by its commercial name Sayana Press, has potential to improve access to contraceptive methods. In Burkina Faso,…”
Get full text

Cost Consequence Analysis of ADMET 2 by Mah, Ethan, Lanctôt, Krista, Chen, Qi Zhen, Shade, Dave, Scherer, Roberta, Vieira, Danielle, Coulibaly, Hamadou, Rosenberg, Paul, Lerner, Alan, Padala, Prasad, Brawman-Mintzer, Olga, van Dyck, Christopher, Porsteinsson, Anton, Mintzer, Jacobo, Herrmann, Nathan

“…Apathy is one of the most common neuropsychiatric symptoms in Alzheimer's disease, affecting up to 70% of patients. This paper uses data from the ADMET 2…”
Get full text

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) by Lanctôt, Krista L, Chen, Clara, Mah, Ethan, Kiss, Alex, Li, Abby, Shade, Dave, Scherer, Roberta W, Vieira, Danielle, Coulibaly, Hamadou, Rosenberg, Paul B, Lerner, Alan J, Padala, Prasad R, Brawman-Mintzer, Olga, van Dyck, Christopher H, Porsteinsson, Anton P, Craft, Suzanne, Levey, Allan, Burke, William J, Mintzer, Jacobo, Herrmann, Nathan

“…This paper used data from the Apathy in Dementia Methylphenidate Trial 2 (NCT02346201) to conduct a planned cost consequence analysis to investigate whether…”
Get more information

Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments by Lanctôt, Krista L., Scherer, Roberta W., Li, Abby, Vieira, Danielle, Coulibaly, Hamadou, Rosenberg, Paul B., Herrmann, Nathan, Lerner, Alan J., Padala, Prasad R., Brawman-Mintzer, Olga, van Dyck, Chris H., Porsteinsson, Anton P., Craft, Suzanne, Levey, Allan, Burke, William J., Mintzer, Jacobo E.

“…•This study operationalized the diagnostic criteria for apathy (DCA) into a clinical rated questionnaire and validated it against the Neuropsychiatric…”
Get full text

Depressive symptoms in relation to clinical symptom onset of mild cognitive impairment by Chan, Carol K, Soldan, Anja, Pettigrew, Corinne, Wang, Mei-Cheng, Wang, Jiangxia, Albert, Marilyn S, Rosenberg, Paul B

“…ABSTRACTObjective:There is increasing evidence of an association between depressive symptoms and mild cognitive impairment (MCI) in cross-sectional studies,…”
Get more information

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment by Chan, Carol K., Soldan, Anja, Pettigrew, Corinne, Wang, Jiangxia, Albert, Marilyn, Rosenberg, Paul B.

“…Introduction We sought to examine whether depressive symptoms and level of Alzheimer's disease (AD) pathology are independently or interactively associated…”
Get full text